These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39253300)

  • 21. Burden of severe spondyloarthritis in France: A nationwide assessment of prevalence, associated comorbidities and cost.
    Claudepierre P; Fagnani F; Cukierman G; de Chalus T; Joubert JM; Laurendeau C; Gourmelen J; Breban M
    Joint Bone Spine; 2019 Jan; 86(1):69-75. PubMed ID: 29709699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.
    Asche CV; Singer ME; Jhaveri M; Chung H; Miller A
    J Manag Care Pharm; 2010; 16(9):703-12. PubMed ID: 21067256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cost of multiple sclerosis in France].
    Fromont A; Lehanneur MN; Rollot F; Weill A; Clerc L; Bonithon Kopp C; Binquet C; Moreau T
    Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of the Width of Uncertainty in Care Consumption and Costs When Using Common Data Collection Tools in Economic Evaluations: A Benchmark for Sensitivity Analyses.
    Daval L; Nze Ossima A; Clément MC; Michel M; Chevreul K
    Value Health; 2021 Oct; 24(10):1416-1422. PubMed ID: 34593164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
    Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
    Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study.
    Veziris N; Andréjak C; Bouée S; Emery C; Obradovic M; Chiron R
    BMC Infect Dis; 2021 Nov; 21(1):1165. PubMed ID: 34789152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The maternal phenylketonuria syndrom--still current problem].
    Didycz B; Domagała L; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data.
    Choong CK; Ford JH; Nyhuis AW; Robinson RL; Aurora SK
    J Manag Care Spec Pharm; 2018 Sep; 24(9):921-928. PubMed ID: 30156448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Appl Health Econ Health Policy; 2011 Nov; 9(6):377-87. PubMed ID: 21888449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal screening and long-term follow-up of phenylketonuria: the French database.
    Abadie V; Berthelot J; Feillet F; Maurin N; Mercier A; de Baulny HO; de Parscau L
    Early Hum Dev; 2001 Dec; 65(2):149-58. PubMed ID: 11641035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data.
    Margolis J; Barron JJ; Grochulski WD
    J Manag Care Pharm; 2005; 11(9):727-34. PubMed ID: 16300416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health Care Utilization and Economic Burdens of Hemochromatosis in the United States: A Population-Based Claims Study.
    Elsaid MI; John T; Li Y; Koduru S; Ali SZ; Catalano C; Narayanan N; Rustgi VK
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1377-1386. PubMed ID: 31778618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019.
    Howe SJ; Lapidus D; Hull M; Yeaw J; Stevenson T; Sampson JB
    Orphanet J Rare Dis; 2022 Feb; 17(1):79. PubMed ID: 35197080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in bacterial sepsis incidence and mortality in France between 2015 and 2019 based on National Health Data System (Système National des données de Santé (SNDS)): a retrospective observational study.
    Pandolfi F; Guillemot D; Watier L; Brun-Buisson C
    BMJ Open; 2022 May; 12(5):e058205. PubMed ID: 35613798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of healthcare costs before and after a STEMI: A French national health data system-based cohort study.
    Serrier H; Rabier H; Fernandez V; Schott AM; Mewton N; Ovize M; Nighoghossian N; Duclos A; Colin C
    J Cardiol; 2024 Jan; 83(1):44-48. PubMed ID: 37524298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France.
    Mounié M; Costa N; Conte C; Petiot D; Fabre D; Despas F; Lapeyre-Mestre M; Laurent G; Savy N; Molinier L
    J Med Econ; 2020 Mar; 23(3):235-242. PubMed ID: 31876205
    [No Abstract]   [Full Text] [Related]  

  • 40. HPLC for confirmatory diagnosis and biochemical monitoring of Cuban patients with hyperphenylalaninemias.
    Contreras J; Alonso E; Fuentes LE
    MEDICC Rev; 2015 Jan; 17(1):23-8. PubMed ID: 25725765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.